These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16816377)

  • 1. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
    Simpson MA
    Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesis.
    Bharadwaj AG; Rector K; Simpson MA
    J Biol Chem; 2007 Jul; 282(28):20561-72. PubMed ID: 17502371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.
    Bharadwaj AG; Kovar JL; Loughman E; Elowsky C; Oakley GG; Simpson MA
    Am J Pathol; 2009 Mar; 174(3):1027-36. PubMed ID: 19218337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice.
    Simpson MA; Wilson CM; McCarthy JB
    Am J Pathol; 2002 Sep; 161(3):849-57. PubMed ID: 12213713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
    Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
    Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
    Liu N; Gao F; Han Z; Xu X; Underhill CB; Zhang L
    Cancer Res; 2001 Jul; 61(13):5207-14. PubMed ID: 11431361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors.
    Jacobson A; Rahmanian M; Rubin K; Heldin P
    Int J Cancer; 2002 Nov; 102(3):212-9. PubMed ID: 12397638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.
    Simpson MA; Wilson CM; Furcht LT; Spicer AP; Oegema TR; McCarthy JB
    J Biol Chem; 2002 Mar; 277(12):10050-7. PubMed ID: 11790779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.
    Rizzardi AE; Vogel RI; Koopmeiners JS; Forster CL; Marston LO; Rosener NK; Akentieva N; Price MA; Metzger GJ; Warlick CA; Henriksen JC; Turley EA; McCarthy JB; Schmechel SC
    Cancer; 2014 Jun; 120(12):1800-9. PubMed ID: 24668563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
    Li Y; Li L; Brown TJ; Heldin P
    Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
    Lokeshwar VB; Cerwinka WH; Lokeshwar BL
    Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
    Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
    Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
    Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
    Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan mediates adhesion of metastatic colon carcinoma cells.
    Laurich C; Wheeler MA; Iida J; Neudauer CL; McCarthy JB; Bullard KM
    J Surg Res; 2004 Nov; 122(1):70-4. PubMed ID: 15522317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
    Kosaki R; Watanabe K; Yamaguchi Y
    Cancer Res; 1999 Mar; 59(5):1141-5. PubMed ID: 10070975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
    Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
    Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
    J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
    Witzel I; Marx AK; Müller V; Wikman H; Matschke J; Schumacher U; Stürken C; Prehm P; Laakmann E; Schmalfeldt B; Milde-Langosch K; Oliveira-Ferrer L
    Breast Cancer Res Treat; 2017 Apr; 162(3):427-438. PubMed ID: 28168629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
    Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
    J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.